The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemia Net integrates 105 national leukemia trial groups and networks, 105 interdisciplinary partner groups and about 1,000 leukemia specialists from 175 institutions. They care for tens of thousands of leukemia patients in 33 countries across Europe. Their ultimate goal is to cure leukemia. Since its inception in 2002, the European Leukemia Net has steadily expanded and has unified leukemia research across Europe. The European Leukemia Net grew from two major roots: 1) the German Competence Network on Acute and Chronic Leukemias; and 2) the collaboration of European Investigators on Chronic Myeloid Leukemia. The European Leukemia Net has improved...
To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic my...
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patien...
Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, m...
The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemi...
Item does not contain fulltextThe EORTC Leukemia Group comprises more than 45 qualified haematology ...
The EORTC Leukemia Group comprises more than 45 qualified haematology centres in Europe. The group p...
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly inv...
The EORTC Leukemia Group (LG) has a long history of promoting the study of leukemias and related mal...
Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres – most of...
Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres - most of...
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patien...
Thanks to modern treatment with all-trans retinoic acid and chemotherapy, acute promyelocytic leukem...
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML...
Purpose: To review and update the European LeukemiaNet (ELN) recommendations for the management of c...
[No abstract available]30SUPPL. 112Hehlman R, Hochhaus A, Baccarani M on behalf of the European Leuk...
To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic my...
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patien...
Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, m...
The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemi...
Item does not contain fulltextThe EORTC Leukemia Group comprises more than 45 qualified haematology ...
The EORTC Leukemia Group comprises more than 45 qualified haematology centres in Europe. The group p...
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly inv...
The EORTC Leukemia Group (LG) has a long history of promoting the study of leukemias and related mal...
Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres – most of...
Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres - most of...
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patien...
Thanks to modern treatment with all-trans retinoic acid and chemotherapy, acute promyelocytic leukem...
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML...
Purpose: To review and update the European LeukemiaNet (ELN) recommendations for the management of c...
[No abstract available]30SUPPL. 112Hehlman R, Hochhaus A, Baccarani M on behalf of the European Leuk...
To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic my...
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patien...
Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, m...